Use of Proteomics To Investigate Kidney Function Decline over 5 Years
- PMID: 28784837
- PMCID: PMC5544512
- DOI: 10.2215/CJN.08780816
Use of Proteomics To Investigate Kidney Function Decline over 5 Years
Abstract
Background and objectives: Using a discovery/replication approach, we investigated associations between a multiplex panel of 80 circulating proteins associated with cardiovascular pathology or inflammation, and eGFR decline per year and CKD incidence.
Design, setting, participants, & measurements: We used two cohorts, the Prospective Investigation of the Vasculature in Uppsala Seniors Study (PIVUS; n=687, mean age of 70 years, 51% women) and the Uppsala Longitudinal Study of Adult Men (ULSAM; n=360 men, mean age of 78 years), with 5-year follow-up data on eGFR. There were 231 and 206 incident cases of CKD during follow-up in the PIVUS and ULSAM studies, respectively. Proteomic profiling of 80 proteins was assessed by a multiplex assay (proximity extension assay). The assay uses two antibodies for each protein and a PCR step to achieve a high-specific binding and the possibility to measure multiple proteins in parallel, but gives no absolute concentrations.
Results: In the discovery cohort from the PIVUS Study, 28 plasma proteins were significantly associated with eGFR decline per year, taking into account the multiple testing. Twenty of these proteins were significantly associated with eGFR decline per year in the replication cohort from the ULSAM Study after adjustment for age, sex, cardiovascular risk factors, medications, and urinary albumin-to-creatinine ratio (in order of significance: TNF-related apoptosis-inducing ligand receptor 2*, CD40L receptor, TNF receptor 1*, placenta growth factor*, thrombomodulin*, urokinase plasminogen activator surface receptor*, growth/differentiation factor 15*, macrophage colony-stimulating factor 1, fatty acid-binding protein*, cathepsin D, resistin, kallikrein 11*, C-C motif chemokine 3, proteinase-activated receptor 1*, cathepsin L, chitinase 3-like protein 1, TNF receptor 2*, fibroblast growth factor 23*, monocyte chemotactic protein 1, and kallikrein 6). Moreover, 11 of the proteins predicted CKD incidence (marked with * above). No protein consistently predicted eGFR decline per year independently of baseline eGFR in both cohorts.
Conclusions: Several circulating proteins involved in phosphate homeostasis, inflammation, apoptosis, extracellular matrix remodeling, angiogenesis, and endothelial dysfunction were associated with worsening kidney function. Multiplex proteomics appears to be a promising way of discovering novel aspects of kidney disease pathology.
Keywords: Adult; Aged; Albumins; Cardiovascular Diseases; Fatty Acid-Binding Proteins; Fibroblast Growth Factors; Follow-Up Studies; Homeostasis; Longitudinal Studies; Phosphates; Plasminogen; Prospective Studies; Proteomics; Urokinase-Type Plasminogen Activator; apoptosis; creatinine; extracellular matrix; glomerular filtration rate; risk factors.
Copyright © 2017 by the American Society of Nephrology.
Figures




Comment in
-
The Possibilities to Improve Kidney Health with Proteomics.Clin J Am Soc Nephrol. 2017 Aug 7;12(8):1206-1208. doi: 10.2215/CJN.06200617. Epub 2017 Jul 21. Clin J Am Soc Nephrol. 2017. PMID: 28733352 Free PMC article. No abstract available.
Similar articles
-
Association between levels of pentraxin 3 and incidence of chronic kidney disease in the elderly.J Intern Med. 2016 Feb;279(2):173-9. doi: 10.1111/joim.12411. Epub 2015 Sep 9. J Intern Med. 2016. PMID: 26355706 Free PMC article.
-
Use of a proximity extension assay proteomics chip to discover new biomarkers associated with albuminuria.Eur J Prev Cardiol. 2017 Mar;24(4):340-348. doi: 10.1177/2047487316676134. Epub 2016 Oct 28. Eur J Prev Cardiol. 2017. PMID: 27794105
-
Circulating proteins as predictors of incident heart failure in the elderly.Eur J Heart Fail. 2018 Jan;20(1):55-62. doi: 10.1002/ejhf.980. Epub 2017 Oct 2. Eur J Heart Fail. 2018. PMID: 28967680
-
Arterial Stiffness and Decline in Kidney Function.Clin J Am Soc Nephrol. 2015 Dec 7;10(12):2190-7. doi: 10.2215/CJN.03000315. Epub 2015 Nov 12. Clin J Am Soc Nephrol. 2015. PMID: 26563380 Free PMC article. Review.
-
Plasma and Urine Biomarkers of CKD: A Review of Findings in the CKiD Study.Semin Nephrol. 2021 Sep;41(5):416-426. doi: 10.1016/j.semnephrol.2021.09.003. Semin Nephrol. 2021. PMID: 34916002 Free PMC article. Review.
Cited by
-
Longitudinal Bottom-Up Proteomics of Serum, Serum Extracellular Vesicles, and Cerebrospinal Fluid Reveals Candidate Biomarkers for Early Detection of Glioblastoma in a Murine Model.Molecules. 2021 Oct 2;26(19):5992. doi: 10.3390/molecules26195992. Molecules. 2021. PMID: 34641541 Free PMC article.
-
Plasma Protein Profile of Incident Myocardial Infarction, Ischemic Stroke, and Heart Failure in 2 Cohorts.J Am Heart Assoc. 2021 Jun 15;10(12):e017900. doi: 10.1161/JAHA.120.017900. Epub 2021 Jun 5. J Am Heart Assoc. 2021. PMID: 34096334 Free PMC article.
-
Elevated Serum Osteoprotegerin is Associated with Reduced Risks of Albuminuria and CKD Progression in Patients with Type 2 Diabetes.Diabetes Metab Syndr Obes. 2022 Dec 12;15:3831-3841. doi: 10.2147/DMSO.S390483. eCollection 2022. Diabetes Metab Syndr Obes. 2022. PMID: 36530588 Free PMC article.
-
Biomarkers of diabetic kidney disease.Diabetologia. 2018 May;61(5):996-1011. doi: 10.1007/s00125-018-4567-5. Epub 2018 Mar 8. Diabetologia. 2018. PMID: 29520581 Free PMC article. Review.
-
Plasma proteomics of acute tubular injury.Nat Commun. 2024 Aug 27;15(1):7368. doi: 10.1038/s41467-024-51304-x. Nat Commun. 2024. PMID: 39191768 Free PMC article.
References
-
- Eckardt KU, Coresh J, Devuyst O, Johnson RJ, Köttgen A, Levey AS, Levin A: Evolving importance of kidney disease: From subspecialty to global health burden. Lancet 382: 158–169, 2013 - PubMed
-
- Coresh J, Turin TC, Matsushita K, Sang Y, Ballew SH, Appel LJ, Arima H, Chadban SJ, Cirillo M, Djurdjev O, Green JA, Heine GH, Inker LA, Irie F, Ishani A, Ix JH, Kovesdy CP, Marks A, Ohkubo T, Shalev V, Shankar A, Wen CP, de Jong PE, Iseki K, Stengel B, Gansevoort RT, Levey AS; CKD Prognosis Consortium : Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. JAMA 311: 2518–2531, 2014 - PMC - PubMed
-
- Holzmann MJ, Aastveit A, Hammar N, Jungner I, Walldius G, Holme I: Renal dysfunction increases the risk of ischemic and hemorrhagic stroke in the general population. Ann Med 44: 607–615, 2012 - PubMed
-
- Matsushita K, Mahmoodi BK, Woodward M, Emberson JR, Jafar TH, Jee SH, Polkinghorne KR, Shankar A, Smith DH, Tonelli M, Warnock DG, Wen CP, Coresh J, Gansevoort RT, Hemmelgarn BR, Levey AS; Chronic Kidney Disease Prognosis Consortium : Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA 307: 1941–1951, 2012 - PMC - PubMed
-
- Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, Coresh J, Gansevoort RT; Chronic Kidney Disease Prognosis Consortium : Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: A collaborative meta-analysis. Lancet 375: 2073–2081, 2010 - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous